`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`SHIRE LABORATORIES, INC.,
`Patent Owner
`____________
`
`Case IPR2017-00011
`Patent RE41,148
`____________
`
`PATENT OWNER MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8(a)(2)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Shire LLC (“Patent Owner”)
`
`Case No. IPR2017-00011
`Reissue Patent No. 41,148
`
`
`
`submits the following Mandatory Notices in response to the Petition for Inter
`
`Partes Review of U.S. Reissue Patent No. 41,148.
`
`I.
`
`Real Party-In-Interest – 37 C.F.R. § 42.8(b)(1)
`
`The real parties-in-interest are Shire Laboratories, Inc. and Shire LLC.
`
`II. Related Matters – 37 C.F.R. § 42.8(b)(2)
`
`Judicial Matters
`
`The following district court litigations concern the challenged U.S. Reissue
`
`Patent RE 41,148 and/or its sister patent RE 42,096.
`
`(1) Shire LLC v. Amerigen Pharms. Ltd., No. 14-cv-6095 (D.N.J filed Oct.
`
`1, 2014);
`
`(2) Shire LLC v. Par Pharm., Inc., No. 15-cv-1454 (D.N.J. filed Feb. 26,
`
`2015);
`
`(3) Shire LLC v. Corepharma, LLC, No. 14-cv-5694 (D.N.J. filed Sept. 12,
`
`2014);
`
`(4) Shire LLC v. Neos Therapeutics, Inc., No. 13-cv-1452 (N.D. Tex.
`
`dismissed by stipulation Aug. 13, 2014);
`
`(5) Shire LLC v. Sandoz, Inc., No. 07-cv-197 (D. Col.);
`
`(6) Shire Labs., Inc. v. Impax Labs, Inc., No. 03-cv-1164 (D. Del.);
`
`(7) Shire Labs., Inc. v. Barr Labs., Inc., No. 03-cv-1219, -6632 (S.D.N.Y.);
`
`1
`
`
`
`
`
`Case No. IPR2017-00011
`Reissue Patent No. 41,148
`
`(8) Shire LLC v. Watson Pharms., Inc., No. 11-cv-02340 (S.D.N.Y.); and
`
`(9) Shire LLC v. Colony Pharms., Inc., No. 07-cv-00718 (D. Md.).
`
`Administrative Matters
`
`RE 41,148 (the challenged patent) claims priority to U.S. Application No.
`
`09/807,462 and is a continuation-in-part of U.S. Application No. 09/ 176,542,
`
`which ultimately reissued as RE42,096. The ‘096 reissue patent is the subject of
`
`Amerigen Pharmaceuticals Ltd. v. Shire LLC, IPR2015-02009 and Mylan
`
`Pharmaceuticals, Inc. v. Shire Labs, Inc., IPR2016-01033.
`
`The Patent Owner is not aware of any other judicial or administrative
`
`matters that would affect, or be affected by, a decision in this proceeding.
`
`
`
`
`
`2
`
`
`
`
`III. Lead and Back-Up Counsel – 37 C.F.R. § 42.8(b)(3)
`
`Case No. IPR2017-00011
`Reissue Patent No. 41,148
`
`Patent Owner provides the following designation of counsel:
`
`Lead Counsel:
`Joseph R. Robinson
`PTO Reg. 33,448
`Troutman Sanders LLP
`875 Third Avenue
`New York, NY 10022
`Phone: 212.704.6246
`Facsimile: 212.704.6288
`joseph.robinson@troutmansanders.com
`
`Back-Up Counsel:
`Robert Schaffer
`PTO Reg. 31,194
`Troutman Sanders LLP
`875 Third Avenue
`New York, NY 10022
`Phone: 212.704.6252
`Facsimile: 212.704.6288
`robert.schaffer@troutmansanders.com
`
`Dustin B. Weeks
`PTO Reg. 67,466
`Troutman Sanders LLP
`Bank of America Plaza
`600 Peachtree Street NE, Suite 5200
`Atlanta, GA 30308-2231
`Phone: 404.885.3446
`Facsimile: 404.962.6848
`dustin.weeks@troutmansanders.com
`
` Power of Attorney is being filed concurrently herewith in accordance with
`
` A
`
`37 C.F.R. § 42.10(b).
`
`
`
`
`
`3
`
`
`
`
`IV. Service Information – 37 C.F.R. § 42.8(b)(4)
`
`Case No. IPR2017-00011
`Reissue Patent No. 41,148
`
`Owner provides the following service information:
`
`
`
`Electronic Mail Addresses:
`
`
`
`
`
`
`
`
`
`
`
`Postal Mailing Address:
`
`
`
`
`
`Telephone Number:
`
`Facsimile Number:
`
`
`
`
`
`
`
`joseph.robinson@troutmansanders.com
`robert.schaffer@troutmansanders.com
`dustin.weeks@troutmansanders.com
`
`Joseph R. Robinson
`Troutman Sanders LLP
`875 Third Avenue
`New York, NY 10022
`
`212.704.6246
`
`212.704.6288
`
`Owner consents to electronic service of all papers concerning this matter at
`
`Respectfully submitted,
`
`/Joseph R. Robinson/
`Joseph R. Robinson
`PTO Reg. No. 33,448
`
`the email addresses provided above.
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: October 24, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`
`Case No. IPR2017-00011
`Reissue Patent No. 41,148
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent Owner
`
`Mandatory Notices Under 37 C.F.R. § 42.8(a)(2) and the associated power of
`
`attorney were served via electronic mail on October 24, 2016 at the following
`
`email addresses provided by Petitioner:
`
`jitty.malik@alston.com
`bryan.skelton@alston.com
`james.abe@alston.com
`brianna.kadjo@alston.com
`
`Respectfully submitted,
`
`/Dustin B. Weeks/
`Dustin B. Weeks
`PTO Reg. No. 67,466
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: October 24, 2016